We heard yesterday that Janet’s biopsy, sent to a reference lab in Birmingham for genetic testing, showed the presence of EGFR, which means the cancer is susceptible to “targeted therapy ” – a tyrosine kinase inhibitor, in our case a drug called afatinab. This is truly good news, because this treatment is twice as effective as standard chemotherapy, and has far fewer side effects.

So over the coming weeks we can look forward to improving health. Thanks be to God.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.